QUOTE AND NEWS
StreetInsider.com  Jun 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Optibase+Ltd+%28OBAS%29+Approves+Sale+of+11+Luxury+Condos+for+%246.4M/9569376.html for the full story.
StreetInsider.com  Mar 31  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Optibase+Ltd+%28OBAS%29+Reports+Q3+EPS+of+%240.06/9331620.html for the full story.
DailyFinance  Jan 2  Comment 
Optibase Ltd. (NASDAQ: OBAS) (the ”Company“ or ”Optibase“) today announced the successful closing of the transaction to purchase twelve luxury condominium units (the “Units”) located in Miami Beach, Florida (the...
DailyFinance  Dec 1  Comment 
Optibase Ltd. (NASDAQ:OBAS) today announced financial results for the third quarter ended September 30, 2013. Revenues from fixed income real estate totaled $3.4 million for the quarter ended September 30, 2013, compared...
Benzinga  Nov 27  Comment 
Eltek (NASDAQ: ELTK) rose 67.14% to $3.56 after the company reported Q3 results. Aetrium (NASDAQ: ATRM) jumped 56.82% to $7.59. Aetrium shares have dropped 19.33% over the past 52 weeks, while the S&P 500 index has gained 27.86% in the same...
Benzinga  Nov 18  Comment 
Optibase (NASDAQ: OBAS) plummeted 15.12% to $5.50. Optibase's trailing-twelve-month ROA is 1.92%. PRGX Global (NASDAQ: PRGX) dropped 13.19% to $6.25 after the company announced the departure of its CEO. Renewable Energy Group (NASDAQ: REGI)...
Benzinga  Nov 13  Comment 
Optibase (NASDAQ: OBAS) today announced that its board of directors approved the purchase by its wholly owned subsidiaries Optibase FMC LLC and Optibase Real Estate Miami LLC, of twelve luxury condominium units located in...
Benzinga  Oct 14  Comment 
Coronado Biosciences (NASDAQ: CNDO) plummeted 67.42% to $1.88 after the company reported that top-line results from Trust-I Phase 2 trial of TSO for Crohn's did not meet primary endpoint. Optibase (NASDAQ: OBAS) dropped 16.57% to $5.74....
Stock Blog Hub  Apr 27  Comment 
Pacira Pharmaceuticals, Inc.(PCRX) recently announced positive data from a phase IV study, EXCLAIM, evaluating the use of Exparel for postsurgical analgesia in patients undergoing four common plastic surgery procedures, namely, abdominoplasty,...
Benzinga  Apr 4  Comment 
Novogen (NASDAQ: NVGN) dropped 16.36% to $5.06. Novogen's trailing-twelve-month operating margin is -628.39%. Entravision Communications (NYSE: EVC) shares lost 10.06% to $2.77. Entravision shares have surged 80.12% over the past 52 weeks,...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki